Decitabine and haemoglobin decreased 
Decitabine and haemoglobin decreased Patient Reports March 18, 2010
Decitabine Side Effects Report #5715719-X
Decitabine side effect was reported by a Physician from ISRAEL on Apr 09, 2008. Female patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: asthma
, dyspnoea, haemoglobin decreased, nervous system disorder, stridor, vocal cord disorder. Decitabine dosage: 30 MG, INTRAVENOUS; 30 MG, INTRAVENOUS. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5730075-9
Decitabine side effect was reported by a Physician from GERMANY on Apr 23, 2008. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: dyspnoea, erysipelas, febrile neutropenia, haemoglobin decreased, mucosal inflammation, myositis
, pneumonia , respiratory failure, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 1 IN 8 HOUR, INTRAVENOUS. Patient was hospitalized. Patient died on 10/12/2006.Decitabine Side Effects Report #5745848-6
Decitabine side effect was reported by a Physician from ITALY on May 07, 2008. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood creatinine increased, haemoglobin decreased, neutropenia, pneumonia
, pneumonitis, thrombocytopenia. Decitabine dosage: 28 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized and became disabled. Patient recovered.Decitabine Side Effects Report #5633774-2
Decitabine side effect was reported by a Physician from VENEZUELA on Feb 07, 2008. Female patient, 74 years of age, weighting 103.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, necrotising fasciitis, platelet count decreased, red blood cell count decreased, skin infection, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 2 IN 1 DAY, INTRAVENOUS; 20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Decitabine Side Effects Report #5646197-7
Decitabine side effect was reported by a Physician from VENEZUELA on Feb 18, 2008. Female patient, 74 years of age, weighting 103.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, necrotising fasciitis, platelet count decreased, septic shock, skin infection, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 2 IN 1 DAY, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 02/15/2008.
Decitabine Side Effects Report #5717276-0
Decitabine side effect was reported by a Physician from VENEZUELA on Apr 17, 2008. Male patient, 73 years of age, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cerebral haematoma, haematocrit increased, haemoglobin decreased, haemorrhagic stroke, hypertensive crisis, platelet count decreased. Decitabine dosage: 15 MG/M2, INTRAVENOUS. During the same period patient was treated with AVANDIA, DIAMICRON, FOLIC ACID, VITAMIN D, GABAPENTIN, LEVOTHYROXINE, ACETAMINOPHEN, ACYCLOVIR. Patient was hospitalized. Patient died on 02/23/2008.
Decitabine Side Effects Report #5876046-3
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Aug 25, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, leukopenia, parotitis. Decitabine dosage: 33 MG, 1 IN 1 DAY, INTRAVENOUS; 25 MG, 1 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5893743-4
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 04, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haematotoxicity, haemoglobin decreased, leukopenia, parotitis. Decitabine dosage: 33 MG, 1 IN 1 DAY, INTRAVENOUS; 25 MG, 1 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5940345-7
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 17, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: anaemia, haematotoxicity, haemoglobin decreased, leukopenia, parotitis. Decitabine dosage: 33 MG, 1 IN 1 DAY, INTRAVENOUS, 25 MG. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5565837-4
Decitabine side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Dec 05, 2007. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, haemoglobin decreased, hepatic failure, infection
, lymphocyte percentage decreased, monocyte percentage increased, multi-organ failure, platelet count decreased. Decitabine dosage: 15 MG/M2, 1 IN 8 HOUR, INTRAVENOUS. During the same period patient was treated with MEDROL. Patient was hospitalized. Patient died on 02/22/2006.Decitabine Side Effects Report #5745891-7
Decitabine side effect was reported by a Physician from CROATIA (local name: Hrvatska) on May 08, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, disease progression, haemoglobin decreased, hepatic failure, infection
, multi-organ failure, sepsis , splenomegaly. Decitabine dosage: 15 MG/M2, 1 IN 8 HOUR, INTRAVENOUS. During the same period patient was treated with MEDROL. Patient was hospitalized. Patient died on 02/22/2006.Decitabine Side Effects Report #5449580-8
Decitabine side effect was reported by a Health Professional from ARGENTINA on Aug 28, 2007. Male patient, 68 years of age, weighting 176.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hypotension, melaena, platelet count decreased, white blood cell count decreased. Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5468289-8
Decitabine side effect was reported by a Health Professional from ARGENTINA on Sept 13, 2007. Male patient, 68 years of age, weighting 176.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastroduodenitis, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hiatus hernia, hypotension, melaena, oesophagitis. Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5328352-9
Decitabine side effect was reported by a Physician from TURKEY on May 07, 2007. Female patient, 64 years of age, weighting 163.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, diarrhoea, haemoglobin decreased, haemorrhage intracranial, hypotension, liver function test abnormal, neutropenia, prothrombin time prolonged. Decitabine dosage: 15 MG/M**2; Q8H; IV. During the same period patient was treated with DEFEROXAMINE MESYLATE. Patient was hospitalized. Patient died on 03/22/2007.
Decitabine Side Effects Report #5839624-3
Decitabine side effect was reported by a Physician from MALAYSIA on Aug 01, 2008. Female patient, 59 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome, serum ferritin increased and was treated with Decitabine. After drug was administered, patient experienced the following side effects: enterobacter infection, haemoglobin decreased, neutrophil count decreased, pathogen resistance, platelet count decreased, skin infection, subcutaneous abscess. Decitabine dosage: 25 MG, INTRAVENOUS; 25 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5567421-5
Decitabine side effect was reported by a Physician from NETHERLANDS on Dec 05, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, tooth abscess, tooth extraction, ulcer
, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 3 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #6030049-7
Decitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2009. Male patient, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, melaena. Decitabine dosage: 20MG/M2, D1-5, IV. During the same period patient was treated with ARSENIC TRIOXIDE, ASCORBIC ACID, LYRICA, METOPROLOL, LISINOPRIL, ZETIA, FLOMAX, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5940346-9
Decitabine side effect was reported by a Physician from SERBIA on Oct 23, 2008. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematemesis, haemoglobin decreased, ileus, platelet count decreased, white blood cell count decreased. Decitabine dosage: unknown. Patient died on 10/22/2008.
Decitabine Side Effects Report #5616220-4
Decitabine side effect was reported by a Physician from POLAND on Jan 22, 2008. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: cardiac arrest
, culture throat positive, haemoglobin decreased, moraxella infection, oesophagitis, oral candidiasis, platelet count decreased, white blood cell count decreased. Decitabine dosage: unknown. During the same period patient was treated with SPIRONOLACTONE. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5626139-0
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 31, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal tenderness, dysphonia, febrile neutropenia, haemoglobin decreased, odynophagia, platelet count decreased, tonsillitis, white blood cell count decreased. Decitabine dosage: 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with FELODIPINE, GLIPIZIDE, METFORMIN, MAGNESIUM OXIDE, SILYMARIN, SENNOSIDE A. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5652150-X
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 22, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal tenderness, febrile neutropenia, haemoglobin decreased, odynophagia, platelet count decreased, tonsillitis. Decitabine dosage: 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS; 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS, 20 MG/M2, 1 IN 1 DAY, INTRAVEN. During the same period patient was treated with FELODIPINE, GLIPIZIDE, METFORMIN, MAGNESIUM OXIDE, SILYMARIN, SENNOSIDE A. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5779744-5
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on June 02, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood culture positive, dyspnoea exertional, ecthyma, haemoglobin decreased, haemoptysis, lung consolidation, lung infiltration, platelet count increased, pleural effusion. Decitabine dosage: 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with FELODIPINE, METFORMIN, GLIPIZIDE, MAGNESIUM OXIDE, SILYMARIN, SENNOSIDE A. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5572439-2
Decitabine side effect was reported by a Physician from AUSTRALIA on Dec 05, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal pain upper, haematemesis, haemoglobin decreased, hepatic steatosis, hepatomegaly, lower respiratory tract infection, neutrophil count decreased, platelet count decreased, pleural effusion. Decitabine dosage: 40 MG, IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5874118-0
Decitabine side effect was reported by a Physician from CZECH REPUBLIC on Aug 19, 2008. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumonitis. Decitabine dosage: 38 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, FLUCONAZOLE, AMOXICILLIN, AUGMENTIN. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5885625-9
Decitabine side effect was reported by a Physician from CZECH REPUBLIC on Aug 29, 2008. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood culture positive, bronchopneumonia, culture urine positive, haemoglobin decreased, klebsiella infection, lung infection, pneumonitis, sputum culture positive, staphylococcal infection
. Decitabine dosage: 38 MG, 1 IN 1 DAY; INTRAVENOUS. During the same period patient was treated with BACTRIM, FLUCONAZOLE, AMOXICILLIN, AUGMENTIN, SUMETROLIM, MYCOMAX, DICYNONE. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5732084-2
Decitabine side effect was reported by a Health Professional from POLAND on Apr 29, 2008. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: genital herpes, haematocrit decreased, haemoglobin decreased, herpes simplex
, oedema peripheral, platelet count decreased, red blood cell count decreased, soft tissue inflammation, white blood cell count decreased. Decitabine dosage: 34.5 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with BENZYDAMINE HYDROCHLORIDE, TAZOBACTAM. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5846227-3
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 07, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, neutropenia, phlebitis, platelet count decreased, pyrexia, thrombosis, vasculitis
. Decitabine dosage: 31.2, MG, IN 1 DAY; INTRAVENOUS, 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5732076-3
Decitabine side effect was reported by a Physician from GERMANY on Apr 29, 2008. Female patient, 76 years of age, weighting 209.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood calcium decreased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, international normalised ratio decreased, platelet count decreased, urinary bladder haemorrhage, white blood cell count decreased. Decitabine dosage: 297 MG,INTRAVENOUS. Patient was hospitalized. Patient died on 03/18/2007.
Decitabine Side Effects Report #5745888-7
Decitabine side effect was reported by a Physician from GERMANY on May 09, 2008. Male patient, 76 years of age, weighting 209.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: bladder tamponade, blood calcium decreased, coagulopathy, disseminated intravascular coagulation, haematocrit decreased, haemoglobin decreased, haemorrhage, platelet count decreased, urinary bladder haemorrhage. Decitabine dosage: 297 MG, INTRAVENOUS. During the same period patient was treated with COTRIM, ALLOPURINOL, HEXORAL, AMPHORONAL, LEVOFLOXACIN. Patient was hospitalized. Patient died on 03/18/2007.
Decitabine Side Effects Report #5777093-2
Decitabine side effect was reported by a Physician from GERMANY on Mar 19, 2007. Male patient, 76 years of age, weighting 209.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood sodium decreased, coagulopathy, disseminated intravascular coagulation, haematocrit decreased, haematuria, haemoglobin decreased, international normalised ratio increased. Decitabine dosage: 297 MG, INTRAVENOUS. During the same period patient was treated with ALLUPURINOL, HEXORAL, AMPHOMORONAL, LEVOFLOXACIN, BACTRIM. Patient was hospitalized. Patient died on 03/18/2007.
Decitabine Side Effects Report #5506432-2
Decitabine side effect was reported by a Physician from TURKEY on Oct 22, 2007. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen abnormal, brain scan abnormal, caecitis, diarrhoea, disease progression, fibrin d dimer increased, haemoglobin decreased, haemorrhage intracranial. Decitabine dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.
Decitabine Side Effects Report #5729578-2
Decitabine side effect was reported by a Physician from TURKEY on Apr 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, haemoglobin decreased, haemorrhage intracranial, hepatic function abnormal, multi-organ failure, platelet count decreased. Decitabine dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.
Decitabine Side Effects Report #5739590-5
Decitabine side effect was reported by a Physician from TURKEY on May 02, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, haemoglobin decreased, haemorrhage intracranial, hepatic function abnormal, hypotension, loss of consciousness, multi-organ failure, neutropenia. Decitabine dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.